Dysmetabolic iron overload syndrome (DIOS)

Area of Science:

• Endocrinology
• Hepatology
• Metabolic Disorders

Background:

• Dysmetabolic iron overload syndrome (DIOS) is characterized by mild iron accumulation in the liver and body.
• It is associated with metabolic syndrome features like obesity, hypertension, dyslipidemia, and abnormal glucose metabolism.
• DIOS presents with hyperferritinemia and normal to moderately elevated transferrin saturation.

Purpose of the Study:

• To define the characteristics of dysmetabolic iron overload syndrome.
• To explore the underlying mechanisms of iron dysregulation in DIOS.
• To outline appropriate therapeutic strategies for DIOS management.

Main Methods:

• Diagnosis relies on identifying mild hepatic iron excess (via MRI or biopsy) alongside metabolic syndrome components.
• Assessment involves evaluating iron parameters (ferritin, transferrin saturation) and metabolic health indicators.
• The study reviews the interplay between diet, genetics, liver, and adipose tissue in iron metabolism alteration.

Main Results:

• DIOS is linked to metabolic syndrome and presents with hyperferritinemia and mild liver iron increase.
• Iron metabolism alterations are multifactorial, involving diet, genetics, and liver-visceral adipose tissue crosstalk.
• Phlebotomy is not recommended; lifestyle modification is the primary treatment.

Conclusions:

• Dysmetabolic iron overload syndrome is a distinct condition requiring specific management approaches.
• Lifestyle modifications, including diet and exercise, are crucial for managing DIOS.
• Pharmacological interventions may be needed for associated metabolic abnormalities.